166 related articles for article (PubMed ID: 35033661)
21. SIRT1 enzymatically potentiates 1,25-dihydroxyvitamin D
Sabir MS; Khan Z; Hu C; Galligan MA; Dussik CM; Mallick S; Stone AD; Batie SF; Jacobs ET; Whitfield GK; Haussler MR; Heck MC; Jurutka PW
J Steroid Biochem Mol Biol; 2017 Sep; 172():117-129. PubMed ID: 28636886
[TBL] [Abstract][Full Text] [Related]
22. Expression of vitamin D receptor decreases during progression of pigmented skin lesions.
Brożyna AA; Jozwicki W; Janjetovic Z; Slominski AT
Hum Pathol; 2011 May; 42(5):618-31. PubMed ID: 21292298
[TBL] [Abstract][Full Text] [Related]
23. The Vitamin D Receptor as Tumor Suppressor in Skin.
Bikle DD
Adv Exp Med Biol; 2020; 1268():285-306. PubMed ID: 32918224
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol potentiates vitamin D and nuclear receptor signaling.
Dampf Stone A; Batie SF; Sabir MS; Jacobs ET; Lee JH; Whitfield GK; Haussler MR; Jurutka PW
J Cell Biochem; 2015 Jun; 116(6):1130-43. PubMed ID: 25536521
[TBL] [Abstract][Full Text] [Related]
25. Function of the vitamin D endocrine system in mammary gland and breast cancer.
Welsh J
Mol Cell Endocrinol; 2017 Sep; 453():88-95. PubMed ID: 28579119
[TBL] [Abstract][Full Text] [Related]
26. Discovery of novel vitamin D receptor interacting proteins that modulate 1,25-dihydroxyvitamin D3 signaling.
Marshall PA; Hernandez Z; Kaneko I; Widener T; Tabacaru C; Aguayo I; Jurutka PW
J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):147-59. PubMed ID: 22626544
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of DJ-1 expression in melanoma regulates PTEN/AKT pathway for cell survival and migration.
Lee YJ; Kim WI; Park TH; Bae JH; Nam HS; Cho SW; Choi YJ; Lee SH; Cho MK
Arch Dermatol Res; 2021 Sep; 313(7):583-591. PubMed ID: 32959108
[TBL] [Abstract][Full Text] [Related]
28. Transcriptomic Response to 1,25-Dihydroxyvitamin D in Human Fibroblasts with or without a Functional Vitamin D Receptor (VDR): Novel Target Genes and Insights into VDR Basal Transcriptional Activity.
Costa PLF; França MM; Katayama ML; Carneiro ET; Martin RM; Folgueira MAK; Latronico AC; Ferraz-de-Souza B
Cells; 2019 Apr; 8(4):. PubMed ID: 30959822
[TBL] [Abstract][Full Text] [Related]
29. Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook.
Reichrath J; Zouboulis CC; Vogt T; Holick MF
Rev Endocr Metab Disord; 2016 Sep; 17(3):405-417. PubMed ID: 27447175
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor FokI polymorphism collectively modulate beta-catenin activity in colon cancer cells.
Egan JB; Thompson PA; Vitanov MV; Bartik L; Jacobs ET; Haussler MR; Gerner EW; Jurutka PW
Mol Carcinog; 2010 Apr; 49(4):337-52. PubMed ID: 20043299
[TBL] [Abstract][Full Text] [Related]
31. VDR independent induction of acid-sphingomyelinase by 1,23(OH)
Albi E; Cataldi S; Ferri I; Sidoni A; Traina G; Fettucciari K; Ambesi-Impiombato FS; Lazzarini A; Curcio F; Ceccarini MR; Beccari T; Codini M
Biochimie; 2018 Mar; 146():35-42. PubMed ID: 29158006
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines.
Evans SR; Houghton AM; Schumaker L; Brenner RV; Buras RR; Davoodi F; Nauta RJ; Shabahang M
J Surg Res; 1996 Feb; 61(1):127-33. PubMed ID: 8769954
[TBL] [Abstract][Full Text] [Related]
33. Stat1-vitamin D receptor interactions antagonize 1,25-dihydroxyvitamin D transcriptional activity and enhance stat1-mediated transcription.
Vidal M; Ramana CV; Dusso AS
Mol Cell Biol; 2002 Apr; 22(8):2777-87. PubMed ID: 11909970
[TBL] [Abstract][Full Text] [Related]
34. 1α,25(OH)2-dihydroxyvitamin D3/VDR protects the skin from UVB-induced tumor formation by interacting with the β-catenin pathway.
Jiang YJ; Teichert AE; Fong F; Oda Y; Bikle DD
J Steroid Biochem Mol Biol; 2013 Jul; 136():229-32. PubMed ID: 23026511
[TBL] [Abstract][Full Text] [Related]
35. Antiproliferative Activity of Double Point Modified Analogs of 1,25-Dihydroxyvitamin D₂ Against Human Malignant Melanoma Cell Lines.
Piotrowska A; Wierzbicka J; Nadkarni S; Brown G; Kutner A; Żmijewski MA
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26760999
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the biological effects of exogenous and endogenous 1,25-dihydroxyvitamin D
Yang D; Anderson PH; Turner AG; Morris HA; Atkins GJ
J Steroid Biochem Mol Biol; 2016 Nov; 164():374-378. PubMed ID: 26949105
[TBL] [Abstract][Full Text] [Related]
37. A sorafenib-sparing effect in the treatment of thyroid carcinoma cells attained by co-treatment with a novel isoflavone derivative and 1,25 dihydroxyvitamin D3.
Izkhakov E; Sharon O; Knoll E; Aizic A; Fliss DM; Kohen F; Stern N; Somjen D
J Steroid Biochem Mol Biol; 2018 Sep; 182():81-86. PubMed ID: 29702263
[TBL] [Abstract][Full Text] [Related]
38. Actions of 1,25(OH)2-vitamin D3 on the cellular cycle depend on VDR and p38 MAPK in skeletal muscle cells.
Irazoqui AP; Boland RL; Buitrago CG
J Mol Endocrinol; 2014 Dec; 53(3):331-43. PubMed ID: 25316911
[TBL] [Abstract][Full Text] [Related]
39. Stable expression of human VDR in murine VDR-null cells recapitulates vitamin D mediated anti-cancer signaling.
Keith ME; LaPorta E; Welsh J
Mol Carcinog; 2014 Apr; 53(4):286-99. PubMed ID: 23681781
[TBL] [Abstract][Full Text] [Related]
40. Determinants of circulating 1,25-dihydroxyvitamin D3 levels: the role of renal synthesis and catabolism of vitamin D.
Anderson PH; O'Loughlin PD; May BK; Morris HA
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):111-3. PubMed ID: 15225756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]